News Week

Share

News Week

 •  December 11, 2017

For the first time ever, a drug targeting Huntington’s disease was found to be safe—and possibly effective—in humans. To date, no direct treatment for the condition exists. The drug lowered levels of a toxic, mutated form of a protein that is at the root of this neurodegenerative illness, suggesting a path forward for treatment. Huntington's...

News Week

 •  December 11, 2017

Infants born with spinal muscular atrophy, a rare genetic disease, slowly become unable to move, swallow or breathe. Many die before their second birthday. Spinraza, which has been called a miracle drug, was approved late last year but costs $125,000 per dose. Now, a dozen practitioners from top medical institutions around the country have teamed...

News Week

 •  December 7, 2017

From penicillin to vaccines to biologics, pharmaceutical innovation has blessed us with better ways to treat, prevent and even cure disease. But some of the pharmaceutical industry’s most recent “innovations” have nothing to do with health, other than their own financial health. Drug companies are coming up with imaginative – and I would argue...

News Week

 •  December 2, 2017

In an effort to fight America’s opioid crisis, the U.S. Food and Drug Administration (FDA) approved a new form of a drug that helps patients ease their withdrawal symptoms. The drug—called buprenorphine—was previously approved fifteen years ago, in the form of a daily tablet that dissolves under the tongue and then in 2016, the agency approved an...

News Week

 •  October 27, 2017

Updated | Members of the Senate are leaning on the Trump administration to stop holding off on implementing a rule that would punish drug makers for price gouging. The administration has already done so four times, and any further delays would "contradict President Trump’s repeated promises to crack down on unfair drug pricing and [allow] bad...

News Week

 •  October 14, 2017

Max, Rowan and Charlie Vertin’s muscles have been slowly collecting damage since the day they were born. Someday, they will not be able to walk. They will not be able to stand. Eventually, they will not be able to live. The brothers, ages 6 through 11, suffer from a debilitating and deadly genetic condition called Duchenne muscular dystrophy...

News Week

 •  October 13, 2017

As President Donald Trump wields his executive power to roll back portions of Obamacare, a new lawsuit seeks to force his administration to detail why it delayed penalizing drug makers for overcharging for certain prescriptions. The suit, filed Friday by the nonprofit watchdog group Democracy Forward and shared first with Newsweek, pushes the...

News Week

 •  September 26, 2017

A promising drug developed to treat mild-to-moderate Alzheimer’s disease has failed in a final phase trial. On Tuesday, the pharmaceutical company Axovant announced that intepirdine didn’t meet the endpoints of a trial designed to demonstrate the drug’s efficacy. The company reported that at 24 weeks, patients enrolled in the Phase 3 trial—known as...

News Week

 •  May 24, 2017

A marijuana-based drug has shown promising results as a treatment for a rare and deadly form of epilepsy in its first large-scale clinical trial. In the randomized trial of the cannabis derivative, cannabidiol, scientists showed a significant reduction in seizures among children suffering from Dravet syndrome—a complex disease that leads to...